Registration with Journal of Neurology and Experimental Neuroscience (JNEN)
It is mandatory for the corresponding author to register with JNEN electronic manuscript tracking system before submitting an article. All articles should be prepared according below mentioned instructions and submitted with the following files: Cover letter, manuscript, figures and tables including legends, supplementary files (if any).
The cover letter should be addressed to the Editor-in-Chief of the journal and specify the type of article, title of the manuscript, summarize why it should be published and its value addition to the scientific literature.
Manuscript Structure and Specifications
JNEN accommodates a wide range of manuscript structures and considers manuscripts of any length with no restrictions for the number of words, figures, or the length of the supporting information.
All manuscripts should be typed in single column, double-spaced, and include line numbers and page numbers in order to facilitate the review process.
Generally for original research articles, manuscript file should include the following sections, in the below mentioned order: Title, Authors, Affiliations, Abstract, Introduction, Materials & Methods, Results & Discussion, Acknowledgements, References, Figure Legends, Table Legends and Supplementary files, if any. Figures and Tables must be submitted as separate files while submitting online through the editorial manager.
Authors may submit their manuscript files in Word (as .doc or .docx), LaTeX (as .pdf), or RTF format.
Units used in the manuscript must be in accordance with the International System of Units and standardized recommended nomenclature should be used as appropriate. Authors should refer to chemical compounds and biomolecules using systematic nomenclature, preferably using International Union of Pure and Applied Chemistry (IUPAC).
For the manuscripts dealing with the microbial strains and cultures, the public culture collections (ATCC, ECACC, NCTC, NCIMB, MTCC, etc) deposition number should be provided. The PubChem compound identifier (CID) number from the NCBI PubChem Compound database should be provided, if chemical compounds are used for the research. The list of the chemical compounds (with PubChem CID) and the microbial strains (deposition number) should be listed below the keywords section.
Standard abbreviations should be kept to a minimum and defined upon first use in the text whereas non-standard abbreviations should be avoided unless they appear at least four times in the text. Authors must include the list of non-standard abbreviations at the end, immediately before the acknowledgments section of their manuscript. Equations should be inserted in editable format from the equation editor (MathType is highly recommended).
Manuscript file should contain the full article title and a short running title. The full title (maximum of 25 words) should be specific, concise and be a statement of the main finding or conclusion presented in the manuscript that can help the reader to decide whether they should read the text or not. Abbreviations should be avoided within the title. The running title should be a maximum of 6 words in length and should state the theme of the paper.
Authors and Affiliations
All author’s full names should be listed together with their respective affiliations which include the associated lab and/or department, university, or organization, city (pin or zip or post codes), state, country along with the phone numbers and email ids.
The abstract should:
- Render the concept and significance of the work
- Describe the main/primary objective of the study
- Briefly outline how the study was done
- Notify the important results/findings
- Should not exceed 250 words in length.
Graphical Abstract (Optional)
Authors should summarize the contents of the article in a pictorial form that clearly represent the work described in the article. Graphical abstracts (Illustration / Figure) should be submitted as a separate file in the online submission system.
Five to ten keywords representing the main content of the article should be given.
The introduction should illustrate the research objective addressing the problem and help the readers to understand the purpose and significance of the study. This section should include a brief review of the literature search to justify the importance of the study. Also, the section should end with a brief statement of what is being reported in the article.
Material and Methods
The methods section should include the design of the study, methods and protocols, materials used (type of participants, if any), analytical procedures used and other information to allow other interested researchers to be able to reproduce your study.
For studies involving human or animal subjects, a statement detailing IACUC (Institutional Animal Care and Use Committee) /IRB (Institutional Review Board) and/or related ethical approval and consent should be included in the methods section. For further details of the journal editorial policies and ethical guidelines please refer to JNEN Editorial Policies.
Results and Discussion
The results and discussion may be combined into a single section or presented separately. Results section should include the interpretations and / or extrapolations of the readings / results of the analytical procedures with statistical approach, where appropriate. Discussion should help understand the problem and how the outcome of this study advances the current system.
Together, this section should describe the results of the experiments and interpretation with the previous related studies discussing the hypothesis presented as the basis of the study and provides a succinct explanation of the implications of the findings.
Cite references in the text by name and year in parentheses. For e.g.,
Subject area covers many disciplines (Victor, 1981).
This assumption of theory was approved by John and Daniel (1996).
This technique was effectively proved and has been widely reported (Peter, 1991; Goodmann et al., 1995; Black and Smith, 2008; Mandal et al., 2012).
This section should clearly summarize the main conclusions of the research giving clear explanation of their importance and emphasizing on potential future directions.
List of Abbreviations
Authors should provide a list of abbreviations used in the text, and they should be defined in the text at first use.
Conflict of Interest Statement
JNEN follows the recommendations by the International Committee of Medical Journal Editors stating that all financial, commercial or other relationships that might be perceived by the academic community as representing a potential conflict of interest must be disclosed. If no such relationship exists, authors will be asked to declare that the research was conducted in the absence of any interests mentioned. For more details, see Editorial policies.
This is a section to acknowledge persons (specific colleagues, institutions, or agencies) who have made substantial contributions to the design, implementation, acquisition of the data, analysis and interpretation of results and / or who was involved in drafting or revising the manuscript, but who do not fulfill the criteria to be included as an author. A statement about the source (s) of funding including grant numbers should be included, if appropriate.
All citations in the text, figures or tables must be in the reference list and vice-versa. References must be listed at the end of the manuscript and numbered in the order that they appear in the text. In the text, citations should be indicated by the reference number in square brackets. Journal abbreviations follow Index Medicus/MEDLINE. Only published or accepted manuscripts should be included in the reference list. For accepted but unpublished works, use “in press” instead of page numbers. Any inclusion of verbatim text must be contained in quotation marks and clearly reference the original source.
Examples of the JNEN reference style
Mathew P, Dun E, Luo JJ. 2013. A Cyclic Pain: The Pathophysiology and Treatment of Menstrual Migraine. Obstet Gynecol Surv 68(2): 130-140. https://doi.org/10.1097/OGX.0b013e31827f2496
In press article
Dun SL, Lyu RM, Chen YH, Chang JK, Luo JJ, et al. 2013. Irisin immunoreactivity in neural and non-neural tissue of the rodent. Neuroscience (In Press).
Luo JJ, Wallace WC, Wei W, Wallace M, Norton D, et al. 2001. The extracellular fragment of amyloid precursor protein produced by beta-secretase induces neuronal apoptosisatase. The 41st Annual meeting of the American Society for Cell Biology, Washington, D.C, USA.
Blum K. 2013. Molecular neurobiology of addiction recovery: the 12 steps program and fellowship. Springer, New York.
Article or Book chapter within a book
Badgaiyan, RD. 2014. Imaging Dopamine Neurotransmission in Live Human Brain. In: Diana M, Chiara GD, Spano P (eds) Progress in Brain Research: Dopamine. Elsevier 211: pp 167-184.
Link / URL
The Mouse Tumor Biology Database. [http://tumor.informatics.jax.org/mtbwi/index.do]
Clinical trial registration record
Mendelow, AD. Surgical Trial in Lobar Intracerebral Haemorrhage. Current Controlled Trials, 2006. https://doi.org/10.1186/ISRCTN22153967
Report of International Science Meets / Initiatives
World Health Organization Global initiative for the elimination of avoidable blindness. An informal consultation. WHO/PBL/97. 61. Geneva: WHO, 1997.
Figure and Table Legends
Figures and Tables files (including legends) must be submitted as separate files, not embedded in manuscript text. Legends should be included in the manuscript file and should be placed at the end of the manuscript. Legends are required to have a short title of 18 words or less and should describe the message of the figure or table. Legends should be preceded by the appropriate label, for example ‘Figure 1’ or ‘Table 1’. Figure panels are referred to by bold capital letters in brackets: (A), (B), (C), (D), etc.
Tables: Tables should be created in Word, Excel or LaTeX and have a concise title. They must be primarily cell-based and editable. Graphics or colored fonts are not acceptable, instead bold or italic can be used to emphasize. Tables should be self-explanatory and include units in the column/row headings.
Figures: Figures should be of high-resolution files submitted in TIFF (or JPEG) or EPS (or PDF). Photos (both B/W and color) should be at least 300 dpi and line drawings 600 dpi. For certain scenarios such as need to print high-quality graphics, authors may be requested to submit higher resolution graphics.
Color Image Mode
Images must be submitted in the color mode RGB.
Drugs, Devices and Names
For drugs and devices, the generic names should be used. If required, the brand name or proprietary name (along with the name and address of the manufacturer) should be in parentheses, and defined in the manuscript at first use. Thereafter, the generic name should be used.
Chemical structures should be prepared using ChemDraw or other drawing programs and should select settings as close as possible according to the following given below:
Drawing settings: chain angle – 120 degrees; bond spacing – 18% of width; bond length – 14.4 pt; bold width – 2.0 pt; line width – 0.6 pt; margin width – 1.6 pt; hash spacing – 2.5 pt.
Text settings: Atom labels and captions font – Arial or Helvetica; size – 10 pt.
The databases for which we can can provide direct links in the manuscript are: GenBank at the NCBI (GenBank), EMBL Nucleotide Sequence Database (EMBL), Protein Data Bank (PDB), Protein Information Resource (PIR), Swiss-Prot Protein Database (Swiss-Prot) and DNA Data Bank of Japan (DDBJ).
The Accession Numbers of any nucleic acid sequences, protein sequences or atomic coordinates cited in the manuscript must be provided in square brackets and include the corresponding database name (for example, [GenBank: JN872327]).
Authors are recommended to submit a ‘mark image’ that can be used to represent their article online in the journal homepage, table of contents, etc. Mark images should be single, high resolution, eye-catching image and ideally a cropped / full portion of image taken from the figures or raw images submitted as supporting information of the article. If no image is submitted, a figure from the paper will be designed as the mark image. Please do not submit any figures or photos that have been previously copyrighted unless you have explicit written permission from the copyright holder to publish.
For original full-length research articles and review articles, a synopsis are required which reflect in the content to represent their article online in the journal homepage, table of contents, etc. The content should specify the significance and emphasize the highlights of the research findings relative to the prior published studies or reports.
The data which is not of primary importance or cannot be included in the article because of its large size (array data, excel files, large size raw images etc.) or the current format (such as movies, raw data traces, power point presentations, etc.) can be uploaded as supplementary material during the submission procedure. The Supplementary Material can be uploaded as Figures (.FIG) and 3D imaging data (NIfTI), Data Sheet (word, excel, csv, fasta, pdf or zip files), Presentation (power point, pdf or zip files), Audio (mp3, wav or wma) or Movie (avi, divx, flv, mov, mp4, mpeg, mpg or wmv).
Authors should include all the necessary ethical guidelines and other guidelines for specific research areas in the manuscript accordingly.
Guidelines for other article types
Articles that provide systematic, critical and constructive analyses of previously published material in a specific field, help in identifying research gaps and summarize the current understanding in the specific research field would be considered as review articles. The manuscript structure remains the same as mentioned for original full length research articles except that there would be a “review” / “body” instead of “results and discussion” section. The materials and methods section should contain for example the information about: selection criteria of studies, source of data / databases, search strategies, number of studies screened and included, treatment methods, statistical methods, softwares used, etc. The main content of the review article should focus on analyses of previously published methodological approaches, models tested, studies/theories that agree or disagree with each other etc. The text must be organized in chronological order and if applicable write each ideas/topics from different geographical location in separate paragraphs. It is important that the authors organize the different pieces on information logically justifying the objective of the review. The conclusions should answer the research questions mentioned in the introduction and gives a message that integrates the points discussed in the review which recommend new research areas.
Studies of the clinical investigations and / or observations should begin with an organized abstract that explain the purpose, study design, methods including selection procedure, primary outcome of the study and conclusion with their clinical relevance. After that the manuscript should follow the standard format: introduction describing the study principle, design and objectives; materials & methods used and types of analysis, presentation of results with discussion on safety and adverse events explaining the risk/benefit assessment and conclusions. In studies involving animals, a statement describing the care of animals and details of IACUC ethical approval should be included in the manuscript.
In studies involving animals, a statement describing the care of animals and details of IACUC ethical approval should be included in the manuscript. In studies involving experimental investigations, a declarative sentence stating that informed consent was obtained from the participants and the study was reviewed by the respective federal or appropriate ethics committee or IRB or that no IRB approval was required, must be included in the manuscript.
Case report should begin with well-defined expressive abstract followed by the sections: introduction, case report(s), discussion and references. Author should state the potential impact of the case report to the medical scientific community in the abstract.
Clinical Trial Registration
In order for clinical trial results to be considered for publication in our journal (which adhere to ICMJE standards), all clinical trials that start recruiting patients or volunteers must be registered with a public registry before the enrolment of the first subject. This ensures that everyone can find key information about every clinical trial whose principal aim is to shape medical decision-making.
The ICMJE accepts registration of clinical trials in the following registries:
- https://eudract.ema.europa.eu/ (new registrations after June 20, 2011)
In addition to the above registries, starting in June 2007 the ICMJE will also accept registration in any of the primary registries that participate in the WHO International Clinical Trials Portal (see http://www.who.int/ictrp/network/primary/en/index.html).
Letters to Editors
Letters to editors are generally, articles written in reference to the article (s) previously published in the journal. The article should comment or make suggestions to the work published previously and help in enhancing knowledge and to find way towards future research needs.
The journal also publishes invited editorials, editorial comments, etc.
JNEN reserves the right to reject the manuscripts publication that do not meet the technical or ethical standards (COPE) according to the editorial policies and retract publications if any breach and / or misconduct of ethical standards, dispute of interests comes to light during post-publication peer review process.
It is the sole responsibility of the authors to make sure that their research article does not include any plagiarized content and/or breach the ethical guidelines and the publishers are not responsible for any such scientific misconduct. JNEN vows to strictly adhere to all the policies and guidelines related to scientific publishing (as mentioned in the Publishing Policies and Guidelines section) and if any misconduct is detected at any time during the publication process, JNEN has the right to retract an article or publish erratum under the advice of the Editor-in-Chief.
Withdrawing a manuscript after the review process / during the production process / after the release of galley proof, wastes valuable resources and a tremendous amount of effort made in processing by the editor, reviewers and other editorial staff. To evade the withdrawal of articles and to encourage generous submissions, JNEN declares a withdrawal policy of charging 97USD to the authors as a withdrawal fee (incurred on man hours, processing tools and software’s used).